futibatinib plus pembrolizumab for the treatment of advanced or metastatic urothelial carcinoma
Published 2 years ago • 268 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
0:30
enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
1:49
blc2001: erdafitinib for the treatment of metastatic urothelial carcinoma
-
2:10
initial ev-103 results: enfortumab vedotin plus pembrolizumab for urothelial carcinoma
-
6:01
enfortumab vedotin plus pembrolizumab improves overall survival for advanced bladder cancer
-
1:17
recent treatment approvals for metastatic and advanced urothelial carcinoma
-
3:24
enfortumab vedotin as treatment for urothelial carcinomas
-
3:45
fierce-22 trial: vofatamab with pembrolizumab for urothelial carcinoma
-
20:21
targeted therapy for the treatment of advanced metastatic urothelial cancer youtube
-
3:37
optimal treatment strategies for patients with metastatic urothelial carcinoma
-
4:34
optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
-
3:25
enfortumab vedotin with pembrolizumab for bladder cancer
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
2:55
ev-103: enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carc...
-
4:00
overview of urothelial carcinoma treatment landscape – the promise of immunotherapy
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
1:09
keynote-045 – pembrolizumab as second-line treatment in urothelial carcinoma
-
1:17
recent advances in the treatment of upper tract urothelial carcinoma